Grey Market Premium, or GMP, is usually the first number retail investors look at before applying for an IPO. It is fast, exciting, easy to understand, and directly linked to the hope of listing gains. But it is also unofficial, volatile, and incomplete.
IPO Lens was built with a simple belief: IPO research should not be reduced to one noisy number. A good IPO decision needs a broader view — demand, fundamentals, valuation, risks, issue structure, and plain-English explanation.
IPO Lens view: GMP can be useful as a sentiment signal, but it should not become the whole research process. A score based only on GMP may reward hype and ignore risk.
First, what exactly is GMP?
GMP stands for Grey Market Premium. It is the unofficial premium at which IPO shares are discussed or traded in the grey market before listing. For example, if an IPO has an issue price of ₹100 and the grey market premium is ₹20, traders may talk about an implied listing sentiment of around ₹120.
But this is not an official exchange price. It is not the final listing price. It is not a guarantee. It is a sentiment indicator that can change quickly with market mood, subscription numbers, rumours, and demand-supply conditions.
Beginner takeaway: GMP tells you what the market may be expecting. It does not tell you whether the company is financially strong, fairly valued, or safe for long-term investors.
Why relying only on GMP can mislead investors
There are three major problems with judging an IPO only by GMP.
1. GMP is unofficial and outside the formal IPO process
Official IPO data comes from stock exchanges, SEBI filings, registrars, and company offer documents. GMP does not come from that formal process. It is generated in an unofficial grey market, where transparency is limited.
2. GMP may move faster than fundamentals
GMP can change because of market mood, social media buzz, subscription excitement, or temporary demand. But the company’s business quality does not change every few hours. Revenue growth, PAT trend, debt, cash flow, and valuation need slower and deeper analysis.
3. GMP ignores downside risk
A high GMP may make an IPO look attractive, but it does not automatically reveal customer concentration, high debt, weak profits, aggressive valuation, SME liquidity issues, or poor use of IPO proceeds.
🔍 IPO Lens Score Drivers Snapshot
Weighted ModelSo what does IPO Lens Score look at?
The IPO Lens Score is designed as a rule-based educational signal. It does not try to predict guaranteed listing gains. Instead, it tries to answer a more useful beginner question:
“Is this IPO supported by enough data, demand, business quality and valuation comfort — or is the excitement mostly hype?”
1. Subscription Demand
Checks retail, QIB, NII/HNI and total demand. Strong demand matters more when it is broad-based.
2. GMP Momentum
Uses GMP as a sentiment input, but gives it limited weight because it is unofficial and volatile.
3. Financial Strength
Looks at revenue growth, PAT trend, margins, debt, ROE/ROCE and consistency of performance.
4. Valuation Comfort
Checks whether the IPO valuation looks reasonable compared with peers, growth and profitability.
5. Risk Factors
Reads key risks such as high debt, customer concentration, litigation, dependency, and SME concerns.
6. Objects of Issue
Checks whether IPO money is going toward growth, debt reduction, working capital, OFS, or corporate purposes.
7. SME Liquidity Risk
For SME IPOs, the score adds extra caution for low liquidity, small scale, and post-listing exit risk.
8. Lead Manager & Quality
Looks at lead manager history, background risks, source confidence and missing data warnings.
GMP vs subscription vs fundamentals
These three signals answer different questions. Treating them as the same can create wrong conclusions.
| Signal | What it tells you | What it does not tell you |
|---|---|---|
| GMP | Unofficial market mood before listing. | Business quality, fair valuation, or guaranteed listing gains. |
| Subscription | Demand across investor categories during the IPO window. | Whether the business is good for long-term holding. |
| Fundamentals | Revenue, profit, margins, debt, cash flow and business strength. | Short-term listing excitement. |
| Valuation | Whether investors are paying a reasonable price for growth. | Whether allotment or listing gain will happen. |
| Risks | What can go wrong after you apply or after listing. | Market sentiment on listing day. |
How to read the IPO Lens Score
The score is not a buy/sell/apply recommendation. It is a research shortcut that helps you understand the quality of available signals.
| Score Range | Label | Plain-English meaning |
|---|---|---|
| 80–100 | Strong Research Signal | Multiple indicators look supportive, but valuation and risks still need review. |
| 65–79 | Positive Research Signal | Data looks encouraging, but some factors may need caution. |
| 50–64 | Neutral / Mixed | Some signals are positive, but the case is not strong enough on its own. |
| 35–49 | Weak / Risky | Missing data, weak demand, high valuation or risk factors may dominate. |
| Below 35 | High Caution | The IPO may need deeper review before a beginner considers it. |
Important: A high score does not guarantee listing gain. A low score does not guarantee poor listing. IPO Lens is designed to support research, not replace your judgement.
Example: Why a score can be positive even with SME caution
In the sample IPO Lens dashboard, the IPO score is shown as 73/100 with a positive research signal. The reasons include very high subscription demand, positive GMP premium, and consistent financial track record. But the same card also highlights SME IPO: higher liquidity risk.
This is exactly how IPO Lens should work. It should not hide the risk just because demand looks strong. A normal investor needs both sides: why the IPO is attracting attention and what can go wrong.
Why SME IPOs need extra caution
SME IPOs can offer interesting growth opportunities, but they may also carry higher risk. Smaller companies may have limited operating history, lower liquidity after listing, wider spreads, more business concentration, and higher volatility.
For SME IPOs, IPO Lens gives more importance to liquidity, issue size, lead manager quality, promoter/background risk, customer concentration, financial consistency and post-listing exit risk.
What IPO Lens will not do
To keep the platform responsible, IPO Lens should avoid language that sounds like guaranteed advice. The platform should not say “must apply,” “sure listing gain,” or “best IPO to buy.”
Instead, the correct language is:
- Strong research signal
- Positive demand signal
- Valuation needs review
- SME liquidity risk present
- Research before applying
Final takeaway
GMP is unofficial and not guaranteed. A serious IPO research page should help investors understand the full picture: what the company does, how the business is performing, how expensive the IPO is, whether demand is broad-based, what the risks are, and whether the data is verified.
IPO Lens does not ignore GMP. It simply refuses to worship it.
That is the difference between hype-driven IPO tracking and research-driven IPO intelligence.
Research the next IPO beyond GMP
Open IPO Lens to check GMP, subscription, financials, valuation, risks and plain-English summaries in one research view.
Explore Live IPOs →Sources and further reading
- SEBI Public Issues filings — official DRHP/RHP/final offer document categories.
- SEBI investor advisory on SME segment companies — cautions investors to conduct research, verify information and understand SME risks.
- Groww explainer on IPO GMP — explains GMP as an unofficial and unregulated grey market premium and notes that it is not a guarantee.
- Reuters on HDB Financial IPO pricing — reports bankers saying IPO pricing was based on fundamentals, not grey market premium.
Disclaimer: This article is for educational and informational purposes only. IPO Lens does not provide investment advice, IPO recommendations, buy/sell/hold calls, or guaranteed return opinions. IPO investments are subject to market risks. GMP is unofficial and not guaranteed. Please read the DRHP/RHP and consult a qualified financial advisor before making investment decisions.